Entecavir is a potent nucleoside analogue that inhibits the DNA polymerase of the hepatitis B virus, preventing its replication and reducing viral load.
Recommended for:
adults with confirmed chronic hepatitis B
patients showing signs of liver inflammation
individuals requiring long-term antiviral suppression
those with compensated liver function
Treatment of chronic hepatitis B in adults with active viral replication and liver inflammation.
Take orally once daily on an empty stomach as prescribed. Treatment duration varies based on clinical response and liver status, often requiring long-term use.
Not recommended during pregnancy, breastfeeding, or for children. Possible side effects include headache, fatigue, nausea, and elevated liver enzymes. Use under physician supervision.
